ELAN — Elanco Animal Health Cashflow Statement
0.000.00%
Last trade - 00:00- $6.55bn
- $11.97bn
- $4.42bn
- 40
- 47
- 78
- 55
Annual cashflow statement for Elanco Animal Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 67.9 | -560 | -472 | -78 | -1,231 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 69.3 | -38.7 | 480 | 367 | 1,188 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -228 | 166 | -87 | -462 | -300 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 224 | -41 | 483 | 452 | 271 |
| Capital Expenditures | -197 | -311 | -197 | -184 | -154 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | -37.4 | -4,468 | -333 | 5 | -15 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -235 | -4,779 | -530 | -179 | -169 |
| Financing Cash Flow Items | -184 | -119 | 33 | -47 | -6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -305 | 4,954 | 210 | -549 | -83 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -332 | 160 | 132 | -293 | 7 |